Organ‐on‐a‐chip technologies for biomedical research and drug development: A focus on the vasculature

Abstract

Current biomedical models fail to replicate the complexity of human biology.Consequently, almost 90% of drug candidates fail during clinical trials after decades of research and billions of investments in drug development. Despite their physiological similarities, animal models often misrepresent human responses, and instead, trigger ethical and societal debates regarding their use. The overall aim across regulatory entities worldwide is to replace, reduce, and refine the use of animal experimentation, a concept known as the Three Rs principle. In response, researchers develop experimental alternatives to improve the biological relevance of in vitro models through interdisciplinary approaches. This article highlights the emerging organ-on-a-chip technologies, also known as microphysiological systems, with a focus on models of the vasculature. The cardiovascular system transports all necessary substances, including drugs, throughout the body while in charge of thermal regulation and communication between other organ systems. In addition, we discuss the benefits, limitations, and challenges in the widespread use of new biomedical models. Coupled with patient-derived induced pluripotent stem cells, organon-a-chip technologies are the future of drug discovery, development, and personalized medicine. K E Y W O R D Sbiomedical, microphysiological systems, models, organ-on-a-chip, vasculatureThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Modeling, applications and challenges of inner ear organoid

“…In addition, it needs to be noted that because the isolated and pooled supporting cells from the cochlea are cultured under homogenous conditions, precise information on cell type and anatomical structure is not available for cochlear organoids for cells that undergo damage or regeneration. Organoids can also be used to build organ chips for biomedical research and drug development 63,64 …”

Developing organs‐on‐chips for biomedical applications

“…With these efforts, organs‐on‐chip systems have demonstrated value in reappearing crucial structural and functional features of human organs. Therefore, organs‐on‐chips are applicable to investigate the underlying biological and pathogenesis mechanisms of specific organ/tissue models 60–62 . For example, Sances et al.…”

Bone Organoids: Recent Advances and Future Challenges

“…The creation of bone organoids presents a significant challenge in the field of tissue engineering, namely the issue of vascularization. [ 116 ] The intricate blood supply of bone is comprised of periosteal vessels and trophoblastic vessels, which intricately branch into capillaries throughout the osteon lamella and Haversian canals, providing essential nutritional support for bone growth and development. While current techniques for constructing bone organoids rely on artificial nutrition supplies in vitro, such methods may prove insufficient when applied to the repair of bone defects, thereby making vascularization an unavoidable problem.…”